A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
Background: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based,...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | International Journal of Preventive Medicine |
Subjects: | |
Online Access: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=134;epage=134;aulast=Gupta |
_version_ | 1818823758383677440 |
---|---|
author | Arti Gupta S Sathiyanarayanan Rajeev Aravindakshan Rakesh Kakkar |
author_facet | Arti Gupta S Sathiyanarayanan Rajeev Aravindakshan Rakesh Kakkar |
author_sort | Arti Gupta |
collection | DOAJ |
description | Background: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based, validated, good quality, cost appropriate, and sustainable risk assessment score for NCD for developing countries like India. Methods: This descriptive retrospective study of diabetic camp data of 84 patients was conducted. A risk score having 10 questions and three measurements for NCDs appropriate for Indian communities was generated. It was compared to IDRS, FINDRISC, FRS, CBAC, and WHO/ISH prediction charts. Results: The study finally included 36 patients with NCD as case and 44 subjects without NCD as control. The means of weight, waist circumference, blood pressure, and blood sugar were significantly different among the two groups. AMNRAS of more than 14 was highly predictive for an individual to be at risk of NCD or sub clinical case of NCD requiring evaluation. The proposed cut-off of 8 for AMNRAS, the sensitivity and NPV was highest compared to other score, 88.9% and 84.6%, respectively. Score for the Area under curve was significantly higher for AMNRAS [0.83 (0.74 to 0.92)] compared to other scores. Conclusions: AMNRAS has higher performance parameters than the other five tested in the present study. Other scoring system performs only modestly in discrimination of NCD cases. The accuracy of AMNRAS for NCD risk will have to be determined in large size cohorts. |
first_indexed | 2024-12-18T23:45:04Z |
format | Article |
id | doaj.art-56550079204449be85408931ed2156e3 |
institution | Directory Open Access Journal |
issn | 2008-7802 2008-8213 |
language | English |
last_indexed | 2024-12-18T23:45:04Z |
publishDate | 2021-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | International Journal of Preventive Medicine |
spelling | doaj.art-56550079204449be85408931ed2156e32022-12-21T20:47:14ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132021-01-0112113413410.4103/ijpvm.IJPVM_206_19A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)Arti GuptaS SathiyanarayananRajeev AravindakshanRakesh KakkarBackground: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based, validated, good quality, cost appropriate, and sustainable risk assessment score for NCD for developing countries like India. Methods: This descriptive retrospective study of diabetic camp data of 84 patients was conducted. A risk score having 10 questions and three measurements for NCDs appropriate for Indian communities was generated. It was compared to IDRS, FINDRISC, FRS, CBAC, and WHO/ISH prediction charts. Results: The study finally included 36 patients with NCD as case and 44 subjects without NCD as control. The means of weight, waist circumference, blood pressure, and blood sugar were significantly different among the two groups. AMNRAS of more than 14 was highly predictive for an individual to be at risk of NCD or sub clinical case of NCD requiring evaluation. The proposed cut-off of 8 for AMNRAS, the sensitivity and NPV was highest compared to other score, 88.9% and 84.6%, respectively. Score for the Area under curve was significantly higher for AMNRAS [0.83 (0.74 to 0.92)] compared to other scores. Conclusions: AMNRAS has higher performance parameters than the other five tested in the present study. Other scoring system performs only modestly in discrimination of NCD cases. The accuracy of AMNRAS for NCD risk will have to be determined in large size cohorts.http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=134;epage=134;aulast=Gupta cardiovascular diseaseschecklistdiabetes mellitusdietarynoncommunicable diseaseobesityrisk factorstobaccowaist circumference |
spellingShingle | Arti Gupta S Sathiyanarayanan Rajeev Aravindakshan Rakesh Kakkar A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS) International Journal of Preventive Medicine cardiovascular diseases checklist diabetes mellitus dietary noncommunicable disease obesity risk factors tobacco waist circumference |
title | A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS) |
title_full | A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS) |
title_fullStr | A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS) |
title_full_unstemmed | A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS) |
title_short | A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS) |
title_sort | pilot retrospective study validating noncommunicable disease risk assessment score amnras |
topic | cardiovascular diseases checklist diabetes mellitus dietary noncommunicable disease obesity risk factors tobacco waist circumference |
url | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=134;epage=134;aulast=Gupta |
work_keys_str_mv | AT artigupta apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT ssathiyanarayanan apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rajeevaravindakshan apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rakeshkakkar apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT artigupta pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT ssathiyanarayanan pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rajeevaravindakshan pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rakeshkakkar pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras |